ESPX:CA:TSX-Evolve S&P 500® Enhanced Yield Fund CAD Hedged (CAD)

ETF | Others |

Last Closing

CAD 25.51

Change

-0.21 (-0.82)%

Market Cap

CAD 0.09B

Volume

6.71K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.02 (+0.07%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

N/A

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.12 (-0.61%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.33 (-0.87%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.19 (+0.41%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.07 (+0.29%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.04 (-0.39%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.01 (+0.04%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 2.68B

ETFs Containing ESPX:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.43% 59% D- 60% D-
Dividend Return 7.01% 89% A- 89% A-
Total Return 22.44% 69% C- 68% D+
Trailing 12 Months  
Capital Gain 20.39% 58% F 60% D-
Dividend Return 8.78% 88% B+ 89% A-
Total Return 29.16% 70% C- 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.05% 72% C 56% F
Dividend Return 6.19% 72% C 53% F
Total Return 0.13% 58% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 7.56% 58% F 80% B-
Risk Adjusted Return 81.88% 94% A 90% A-
Market Capitalization 0.09B 61% D- 33% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike